全部

1·Established the IL-2 gene recombinant adenovirus vector.

人IL-2基因腺病毒载体的构建和包装。

2·Objective to construct recombinant adenovirus vector carrying human TRADD gene.

目的构建含有人TRADD基因片段的重组腺病毒载体。

3·Virus without anti-Smad was served as negative control, and that without adenovirus vector was served as blank control.

以空载病毒作为阴性对照组，以无病毒载体作为空白对照组。

4·Objective to construct and express a recombinant adenovirus vector which can regulate expression of human tumor suppressor gene PTEN.

目的体外构建和表达可调控性人抑癌基因pten重组腺病毒。

5·Adenovirus vector is an earlier and maturer genetic carrier in the respect of gene therapy and genetic immunization after retroviral vector.

腺病毒载体是继逆转录病毒载体后在基因治疗、基因免疫等方面应用开发得较早且较成熟的一种基因载体。

6·MDR1 gene was transfered to cord blood nucleate cells (CBNC) mediated by adenovirus vector, for enhancing its resistance to chemotherapeutic drugs.

通过腺病毒载体介导使多药耐药基因转染入脐血有核细胞，提高其对化疗药物的耐受性。

7·Results Fiber-mutant adenovirus vector showed a notably enhanced gene expression in four different tumor cells compared with that of conventional ones.

结果：与野生型腺病毒相比，重组腺病毒能显著地提高目的基因在四种不同肿瘤细胞中的表达。

8·AIM: to construct a recombinant adenovirus vector carrying AFP promoter to specifically express a targeting gene in hepatocellular carcinoma HepG2 cells.

目的：建立一种在甲胎蛋白(afp)阳性的肝癌细胞中靶向表达目的基因的重组腺病毒载体。

9·The failure of the Merck vaccine up on behalf of the non-replicating adenovirus vector vaccine failure, not on behalf of other AIDS vaccines will be no hope.

默克疫苗的失败至多代表非复制型腺病毒载体疫苗的失败，决不代表其他艾滋病疫苗就没有希望。

10·The selection and cloning of early and late promoters and removal of adenovirus terminal protein (TP) are very important in construction of adenovirus vector.

在腺病毒载体的构建过程中，早期和晚期启动子的选择、构建以及去除末端蛋白(TP)、克隆末端序列是至关重要的。